Emerging evidence indicates that ACIN1 is abundantly expressed in lung cancer patients compared to that in healthy individuals and that a high methylation level of ACIN1 predicts a high risk of lung cancer [57,58]. This evidence concerns the gene ACIN1 and lung carcinoma.